Medical Condition News

RSS
Researchers develop new tool to quantify myocardial damage in heart attack patients

Researchers develop new tool to quantify myocardial damage in heart attack patients

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Simple urine test uses nanotechnology to detect dangerous blood clotting

Simple urine test uses nanotechnology to detect dangerous blood clotting

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia awarded U.S. Healthcare Product of the Year for remede System

New app for intelligent glasses could improve gait of Parkinson's disease patients

New app for intelligent glasses could improve gait of Parkinson's disease patients

Proper sleep helps maintain a healthy lifestyle

Proper sleep helps maintain a healthy lifestyle

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

New $1.9M research grant to support investigators to detect tumors in earliest stages of formation

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

Evidence less consistent for high blood sugar, insulin treatment and oral agents

Evidence less consistent for high blood sugar, insulin treatment and oral agents

BWH, Case Western awarded $7.7M NIH grant to establish NHLBI National Sleep Research Resource

BWH, Case Western awarded $7.7M NIH grant to establish NHLBI National Sleep Research Resource

Ticagrelor drug may reduce risk of dying following heart attack

Ticagrelor drug may reduce risk of dying following heart attack

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.